Mitochondrial TDP-43 in Alzheimer's Disease
阿尔茨海默病中的线粒体 TDP-43
基本信息
- 批准号:9815609
- 负责人:
- 金额:$ 54.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-15 至 2020-10-30
- 项目状态:已结题
- 来源:
- 关键词:APP-PS1AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAmyotrophic Lateral SclerosisBehavioralBindingBiochemicalBrainBrain StemCell NucleusCognitionCognitive deficitsComplexCytoplasmDNA Sequence AlterationDementiaDisease ProgressionElderlyEnsureExhibitsExperimental ModelsFrontotemporal DementiaFunctional disorderGeneticGenus HippocampusHippocampus (Brain)ImpairmentInvestigationMeasurementMeasuresMediatingMediator of activation proteinMessenger RNAMitochondriaMolecularMusNADH dehydrogenase (ubiquinone)NeocortexNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronal DysfunctionNeuronsNuclearPathogenesisPathologicPathologyPathway interactionsPatientsPatternPerformancePharmacologyPilot ProjectsPlayPost-Translational Protein ProcessingPreventionProtein BiosynthesisProteinsReportingResolutionRespirationRoleSenile PlaquesSeveritiesSpinal CordSymptomsSynapsesTemporal LobeTestingTissuesToxic effectTransgenic Miceautosomal dominant mutationbasecognitive functionearly onseteffective therapyfrontal lobefrontotemporal lobar dementia-amyotrophic lateral sclerosisimprovedmitochondrial dysfunctionmotor disordermotor neuron degenerationmouse modelneuron lossneuropathologyneurotoxicitynovelnovel therapeutic interventionpreventprotein TDP-43sensorspatiotemporaltau Proteinstreatment strategy
项目摘要
PROJECT SUMMARY
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, characterized by neurofibrillary
tangles, senile plaques and a progressive loss of neuronal cells in neocortex and hippocampus. Currently,
there is no effective treatment for AD. Genetic mutations in TAR DNA-binding protein 43 (TDP-43) cause
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD, the second most common form of
early-onset dementia), and the increased presence of TDP-43 in the cytoplasm is a prominent
histopathological feature of degenerating neurons in more than half of AD patients. Despite an expanding body
of evidence suggests that TDP-43 may be “the third protein” playing a distinct role in the pathogenesis of AD or
related dementia, in addition to amyloid beta (Aβ) and tau, the molecular pathomechanisms of TDP-43 remain
elusive. Interestingly, in our preliminary studies, we found that TDP-43 became highly associated with
mitochondria in AD patients, neurons treated with Aβ and APP/PS1 (5XFAD) transgenic mice for AD. Based
on identified motifs critical for TDP-43 mitochondrial localization, our most recent study revealed that the
suppression of TDP-43 mitochondrial localization was sufficient to prevent TDP-43-induced neuronal loss, and
improve behavioral performances in TDP-43 transgenic mice, indicating mitochondria as important mediators
for TDP-43 neurotoxicity. Excitingly, the inhibition of TDP-43 mitochondrial localization could significantly
alleviate neuronal death and behavioral deficits in 5XFAD mice well after symptom onset. These exciting and
promising preliminary studies suggest that a detailed investigation into the potential role of mitochondria-
associated TDP-43 in AD and related dementia is warranted. Using both cultured neuronal and transgenic
mouse models for AD and related dementia, this study will test the feasibility of targeting mitochondria-
associated TDP-43 as a novel therapeutic approach for AD and related dementia. The increased presence of
TDP-43 in the cytoplasm is a prominent common histopathological feature of degenerating neurons in various
major neurodegenerative diseases including AD, FTD and ALS. Our proposed studies of mitochondria-
associated TDP-43 and its connection with the generally believed AD culprit Aβ will have very broad scientific
and translational significance.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xinglong Wang其他文献
Xinglong Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xinglong Wang', 18)}}的其他基金
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
AD 和相关 tau 病中神经炎症的线粒体调节
- 批准号:
10766083 - 财政年份:2020
- 资助金额:
$ 54.89万 - 项目类别:
Mitochondrial modulation of neuroinflammation in AD and related tauopathies
AD 和相关 tau 病中神经炎症的线粒体调节
- 批准号:
10375646 - 财政年份:2020
- 资助金额:
$ 54.89万 - 项目类别:
Mitochondrial TDP-43 in Alzheimer's Disease
阿尔茨海默病中的线粒体 TDP-43
- 批准号:
10578054 - 财政年份:2019
- 资助金额:
$ 54.89万 - 项目类别:
Mitochondrial TDP-43 in Alzheimer's Disease
阿尔茨海默病中的线粒体 TDP-43
- 批准号:
10766077 - 财政年份:2019
- 资助金额:
$ 54.89万 - 项目类别:
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in ALS
线粒体动力学在衰老过程中和 ALS 中维持神经肌肉接头
- 批准号:
10329077 - 财政年份:2017
- 资助金额:
$ 54.89万 - 项目类别:
TDP-43 and Mitochondrial Dysfunction in ALS
TDP-43 和 ALS 中的线粒体功能障碍
- 批准号:
8799706 - 财政年份:2014
- 资助金额:
$ 54.89万 - 项目类别:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
阐明帕金森病 VPS35 突变的致病机制
- 批准号:
8620854 - 财政年份:2013
- 资助金额:
$ 54.89万 - 项目类别:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
PS1 在线粒体动力学和线粒体功能中的作用
- 批准号:
8490631 - 财政年份:2013
- 资助金额:
$ 54.89万 - 项目类别:
Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease
阐明帕金森病 VPS35 突变的致病机制
- 批准号:
8729045 - 财政年份:2013
- 资助金额:
$ 54.89万 - 项目类别:
Role of PS1 in Mitochondria Dynamics and Mitochondria Function
PS1 在线粒体动力学和线粒体功能中的作用
- 批准号:
8636966 - 财政年份:2013
- 资助金额:
$ 54.89万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 54.89万 - 项目类别:
Research Grant














{{item.name}}会员




